GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Products » Fidia SpA (MIL:FDA) » Definitions » Debt-to-Asset

Fidia SpA (MIL:FDA) Debt-to-Asset : 0.28 (As of Jun. 2023)


View and export this data going back to 2000. Start your Free Trial

What is Fidia SpA Debt-to-Asset?

Fidia SpA's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2023 was €6.12 Mil. Fidia SpA's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2023 was €5.06 Mil. Fidia SpA's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Jun. 2023 was €39.88 Mil. Fidia SpA's debt to asset for the quarter that ended in Jun. 2023 was 0.28.


Fidia SpA Debt-to-Asset Historical Data

The historical data trend for Fidia SpA's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fidia SpA Debt-to-Asset Chart

Fidia SpA Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.34 - 0.29 - 0.36

Fidia SpA Semi-Annual Data
Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Dec21 Jun22 Jun23 Dec23
Debt-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.29 0.21 0.28 0.36

Competitive Comparison of Fidia SpA's Debt-to-Asset

For the Specialty Industrial Machinery subindustry, Fidia SpA's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fidia SpA's Debt-to-Asset Distribution in the Industrial Products Industry

For the Industrial Products industry and Industrials sector, Fidia SpA's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Fidia SpA's Debt-to-Asset falls into.



Fidia SpA Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Fidia SpA's Debt-to-Asset for the fiscal year that ended in Dec. 2022 is calculated as

Fidia SpA's Debt-to-Asset for the quarter that ended in Jun. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Fidia SpA  (MIL:FDA) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.


Fidia SpA Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Fidia SpA's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Fidia SpA (MIL:FDA) Business Description

Traded in Other Exchanges
Address
Corso Lombardia, 11, San Mauro Torinese, Turin, ITA, 10099
Fidia SpA is engaged in the manufacturing and sale of numerical controls and software, high-speed milling systems and after-sales service for the automotive, aerospace, and energy sector. Its products comprise Machines, Numerical Controls, Milling Heads, Accessories, and Software.

Fidia SpA (MIL:FDA) Headlines

No Headlines